At Spotdot Bioinnovations, we develop innovative Point-of-Care in-vitro diagnostics aligned with WHO-ASSURED criteria suitable for resource-limited settings.
Embedded Files
Point-of-care Test for Preeclampsia Screening - a fatal pregnancy disorder
REDSPOT- PE™, is a rapid Point-of-Care Test (POCT), based on Congo red test method is designed to aid in the diagnosis of Preeclampsia (PE).
REDSPOT-PE™ is a simple, 10-minute urine-based test that detects misfolded proteins, known to be present in the urine of patients with preeclampsia. The test is easy to use, requires no special equipment, and can be stored at room temperature. This makes it particularly suitable for OPD settings, where follow-up visits may be inconsistent.
REDSPOT-PE™ enables on-the-spot testing during the patient's initial visit, and is also ideal for triage situations, allowing timely clinical decisions.
For more information: https://www.tulipgroup.com/products-U-redspot.html
Point-of-care Immunoassay Platform
Page updated
Google Sites
Report abuse